Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 15 | Ticho BarryCHIEF MEDICAL OFFICER |  STOKStoke Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $62K 1,989 sh | Dec 5, 2025 |
| 15 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS |  TBPHTheravance Biopharma, Inc.Open-market sale · 10b5-1 plan | SELL | $291K 15.5K sh | Dec 5, 2025 traded Dec 3, 2025 |
| 15 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $52K 1,673 sh | Dec 5, 2025 traded Dec 5, 2025 |
| 15 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $42K 1,373 sh | Dec 5, 2025 traded Dec 4, 2025 |
| 15 | Allan JonathanGENERAL COUNSEL & CORP SEC | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $74K 2,344 sh | Dec 5, 2025 traded Dec 5, 2025 |
| 14 | Campbell Lisa MDirector |  DTDynatrace, Inc.Open-market sale · 10b5-1 plan | SELL | $11K 253 sh | Dec 5, 2025 traded Dec 5, 2025 |
| 13 | Herb TylerChief Accounting Officer | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $43K 1,200 sh | Dec 5, 2025 traded Dec 3, 2025 |
| 13 | Herb TylerChief Accounting Officer | FIGFigma, Inc. Open-market sale · 10b5-1 plan | SELL | $41K 1,110 sh | Dec 5, 2025 traded Dec 3, 2025 |
| 11 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $10K 323 sh | Dec 5, 2025 traded Dec 4, 2025 |
| 11 | Allan JonathanGENERAL COUNSEL & CORP SEC | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $25K 824 sh | Dec 5, 2025 traded Dec 4, 2025 |
| 11 | Allan JonathanGENERAL COUNSEL & CORP SEC | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $6,075 194 sh | Dec 5, 2025 traded Dec 4, 2025 |
| 9 | Gibson ChristopherDirector, Chief Executive Officer |  RXRXRECURSION PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $185K 40.0K sh | Dec 5, 2025 traded Dec 4, 2025 |
| 8 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | TBPHTheravance Biopharma, Inc. Open-market sale · 10b5-1 plan | SELL | $146K 7,766 sh | Dec 5, 2025 traded Dec 3, 2025 |
| 8 | Allan JonathanGENERAL COUNSEL & CORP SEC | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $31K 1,004 sh | Dec 5, 2025 traded Dec 5, 2025 |
| 8 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | TBPHTheravance Biopharma, Inc. Open-market sale · 10b5-1 plan | SELL | $146K 7,767 sh | Dec 5, 2025 traded Dec 3, 2025 |
| 8 | Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICER |  OMCLOMNICELL, INC.Open-market sale · 10b5-1 plan | SELL | $244K 6,106 sh | Dec 5, 2025 traded Dec 3, 2025 |
| 7 |  Dines DanielDirector, CEO and Chairman, 10% Owner |  PATHUiPath, Inc.Open-market sale · 10b5-1 plan | SELL | $819K 45.0K sh | Dec 5, 2025 traded Dec 5, 2025 |
| 7 | Barrett David MichaelDirector, Chief Executive Officer |  EXFYExpensify, Inc.Open-market sale · 10b5-1 plan | SELL | $46K 30.0K sh | Dec 5, 2025 traded Dec 1, 2025 |
| 48 | Sweeny NicoleChief Commercial Officer |  KALVKalVista Pharmaceuticals, Inc.Open-market sale | SELL | $51K 3,813 sh | Dec 4, 2025 traded Nov 24, 2025 |
| 45 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $82K 994 sh | Dec 4, 2025 traded Dec 2, 2025 |
| 45 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $194K 2,378 sh | Dec 4, 2025 traded Dec 2, 2025 |
| 45 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $194K 2,378 sh | Dec 4, 2025 traded Dec 2, 2025 |
| 45 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $65K 793 sh | Dec 4, 2025 traded Dec 2, 2025 |
| 45 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $82K 994 sh | Dec 4, 2025 traded Dec 2, 2025 |
| 44 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $575K 7,335 sh | Dec 4, 2025 traded Dec 2, 2025 |
| 44 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $575K 7,335 sh | Dec 4, 2025 traded Dec 2, 2025 |
| 44 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $487K 6,277 sh | Dec 4, 2025 traded Dec 2, 2025 |
| 44 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $487K 6,277 sh | Dec 4, 2025 traded Dec 2, 2025 |
| 43 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $2.00M 25.8K sh | Dec 4, 2025 traded Dec 2, 2025 |
| 43 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $2.37M 30.2K sh | Dec 4, 2025 traded Dec 2, 2025 |
| 42 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $27K 331 sh | Dec 4, 2025 traded Dec 2, 2025 |
| 42 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $9,787 119 sh | Dec 4, 2025 traded Dec 2, 2025 |
| 42 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $7,739 95 sh | Dec 4, 2025 traded Dec 2, 2025 |
| 42 | Vieira CoryChief Accounting Officer |  PGYPagaya Technologies Ltd.Open-market sale | SELL | $195K 8,442 sh | Dec 4, 2025 traded Dec 2, 2025 |
| 42 | Notman TaliCHIEF REVENUE OFFICER |  FROGJFrog LtdOpen-market sale | SELL | $863K 14.2K sh | Dec 4, 2025 traded Dec 2, 2025 |
| 42 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $23K 285 sh | Dec 4, 2025 traded Dec 2, 2025 |
| 42 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $3,290 40 sh | Dec 4, 2025 traded Dec 2, 2025 |
| 42 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $3,290 40 sh | Dec 4, 2025 traded Dec 2, 2025 |
| 42 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $7,739 95 sh | Dec 4, 2025 traded Dec 2, 2025 |
| 41 | McBee BranninChief Development Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $171K 2,120 sh | Dec 4, 2025 traded Dec 2, 2025 |